Unicycive Therapeutics, Inc.
Support and Resistance Levels
Past performance
News About UNCY
All events for UNCY
All deals for UNCY
Financial Ratios
Financial Statements
UNCY vs Sector & Peers
About Unicycive Therapeutics, Inc.
Unicycive Therapeutics, Inc. is a U.S.-based biotechnology company dedicated to the creation of innovative treatments for kidney diseases. Its development pipeline includes Renazorb, a therapy for hyperphosphatemia in chronic kidney disease patients, and UNI 494, which is being developed to treat acute kidney injury. Founded in 2016, the firm is headquartered in Los Altos, California. Website unicycive.com
Headquarters Mountain View, CA, US